Ee Shien Tan

831 total citations
27 papers, 351 citations indexed

About

Ee Shien Tan is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Ee Shien Tan has authored 27 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 7 papers in Physiology. Recurrent topics in Ee Shien Tan's work include Metabolism and Genetic Disorders (8 papers), Genomics and Rare Diseases (5 papers) and Neonatal Health and Biochemistry (5 papers). Ee Shien Tan is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Genomics and Rare Diseases (5 papers) and Neonatal Health and Biochemistry (5 papers). Ee Shien Tan collaborates with scholars based in Singapore, United States and Australia. Ee Shien Tan's co-authors include Pilar Giraldo, Raul Chertkoff, Мilan Petakov, Saumya Shekhar Jamuar, Angeline Lai, Maureen Cleary, Einat Brill‐Almon, Veronica Wiley, Denise Goh and Catharine John and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and The Journal of Pediatrics.

In The Last Decade

Ee Shien Tan

25 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ee Shien Tan Singapore	12	158	121	76	74	50	27	351
Çiğdem Seher Kasapkara Türkiye	9	167 1.1×	103 0.9×	60 0.8×	90 1.2×	22 0.4×	61	344
Patrice K. Held United States	13	415 2.6×	179 1.5×	187 2.5×	51 0.7×	14 0.3×	31	632
Bing-Zhi Yang United States	13	232 1.5×	159 1.3×	68 0.9×	160 2.2×	36 0.7×	18	445
Jérôme Coulombe Canada	12	68 0.4×	72 0.6×	49 0.6×	25 0.3×	23 0.5×	31	285
Patrick Forny Switzerland	10	213 1.3×	188 1.6×	34 0.4×	32 0.4×	34 0.7×	22	363
Vassiliki Konstantopoulou Austria	14	288 1.8×	344 2.8×	68 0.9×	90 1.2×	20 0.4×	33	484
Vladimir Sarnavka Croatia	10	272 1.7×	179 1.5×	40 0.5×	52 0.7×	17 0.3×	25	445
Sandesh C.S. Nagamani United States	10	180 1.1×	279 2.3×	58 0.8×	60 0.8×	10 0.2×	16	385
Satoshi Tsugawa Japan	11	123 0.8×	48 0.4×	27 0.4×	97 1.3×	54 1.1×	27	289
Bianca T. van Maldegem Netherlands	8	191 1.2×	223 1.8×	57 0.8×	106 1.4×	28 0.6×	13	339

Countries citing papers authored by Ee Shien Tan

Since Specialization

Citations

This map shows the geographic impact of Ee Shien Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ee Shien Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ee Shien Tan more than expected).

Fields of papers citing papers by Ee Shien Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ee Shien Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ee Shien Tan. The network helps show where Ee Shien Tan may publish in the future.

Co-authorship network of co-authors of Ee Shien Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ee Shien Tan. A scholar is included among the top collaborators of Ee Shien Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ee Shien Tan. Ee Shien Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Webber, Lisa, et al.. (2025). Premature ovarian insufficiency: When ovaries retire early. Annals of the Academy of Medicine Singapore. 54(3). 178–191. 2 indexed citations

2.

Lim, Weng Khong, et al.. (2025). National Thalassemia Registry: a 30 year journey of implementing carrier screening in Singapore. The Lancet Regional Health - Western Pacific. 55. 101471–101471. 1 indexed citations

3.

Bylstra, Yasmin, Angela S. Koh, Hak Chiaw Tang, et al.. (2024). Advancing precision medicine through the integration of clinical cardiovascular genetics - An Asian perspective. Genetics in Medicine Open. 2. 101877–101877.

4.

Caeser, Rebecca, Jianbang Chiang, Ee Shien Tan, E Shyong Tai, & Joanne Ngeow. (2024). Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy. Familial Cancer. 23(2). 133–140. 1 indexed citations

5.

Paul, Franziska, Fathiya Al-Murshedi, Breana Cham, et al.. (2023). Inactivation of DRG1, encoding a translation factor GTPase, causes a recessive neurodevelopmental disorder. Genetics in Medicine. 25(9). 100893–100893. 1 indexed citations

6.

Zhong, Youjia, Jian Yi Soh, Chia Yin Chong, et al.. (2022). Implementation of Universal Newborn Screening for Severe Combined Immunodeficiency in Singapore While Continuing Routine Bacille-Calmette-Guerin Vaccination Given at Birth. Frontiers in Immunology. 12. 794221–794221. 15 indexed citations

7.

Tan, Ee Shien, et al.. (2020). Enzyme replacement therapy desensitization in a child with infantile onset Pompe disease. Asian Pacific Journal of Allergy and Immunology. 40(4). 414–417. 5 indexed citations

8.

Wei, Heming, Angeline Lai, Ee Shien Tan, et al.. (2020). Genetic landscape of congenital disorders in patients from Southeast Asia: results from sequencing using a gene panel for Mendelian phenotypes. Archives of Disease in Childhood. 106(1). 38–43. 5 indexed citations

9.

Goh, Liuh Ling, et al.. (2018). Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report. BMC Medical Genomics. 11(1). 37–37. 18 indexed citations

10.

Bjoraker, Kendra, Michael A. Swanson, Curtis R. Coughlin, et al.. (2016). Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia. The Journal of Pediatrics. 170. 234–239. 47 indexed citations

11.

Zimran, Ari, Aya Abrahamov, Peter A. Cooper, et al.. (2016). Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imiglucerase. Blood Cells Molecules and Diseases. 68. 163–172. 27 indexed citations

12.

Jamuar, Saumya Shekhar, Jyn Ling Kuan, Maggie Brett, et al.. (2016). Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?. EBioMedicine. 5. 211–216. 17 indexed citations

13.

Jamuar, Saumya Shekhar, Ee Shien Tan, Breana Cham, et al.. (2015). Left Ventricular Non-compaction: Is It Genetic?. Pediatric Cardiology. 36(8). 1565–1572. 9 indexed citations

14.

Jamuar, Saumya Shekhar, Christina Ong, Koh Cheng Thoon, et al.. (2015). Tricho-hepato-enteric syndrome (THE-S): two cases and review of the literature. European Journal of Pediatrics. 174(10). 1405–1411. 14 indexed citations

15.

Pastores, Gregory M., Мilan Petakov, Pilar Giraldo, et al.. (2014). A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. 53(4). 1 indexed citations

16.

Ong, Christina, et al.. (2014). Urinary reducing substances in neonatal intrahepatic cholestasis caused by citrin deficiency. SHILAP Revista de lepidopterología.

17.

Tan, Ee Shien, Catharine John, Enzo Ranieri, et al.. (2014). Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8year journey from pilot to current program. Molecular Genetics and Metabolism. 113(1-2). 53–61. 55 indexed citations

18.

Pastores, Gregory M., Мilan Petakov, Pilar Giraldo, et al.. (2014). A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. Blood Cells Molecules and Diseases. 53(4). 253–260. 46 indexed citations

19.

Jamuar, Saumya Shekhar, et al.. (2011). Use of deferiprone for iron chelation in patients with transfusion‐dependent thalassaemia. Journal of Paediatrics and Child Health. 47(11). 812–817. 11 indexed citations

20.

Tan, Ee Shien, Veronica Wiley, Kevin Carpenter, & Bridget Wilcken. (2007). Non-Ketotic Hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening. Molecular Genetics and Metabolism. 90(4). 446–448. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact